• Provides valuable information for academic clinicians, researchers, bioengineers and industry on diabetes and retinopathy
• Discusses the impact of diabetic retinopathy, a major cause of new-onset visual loss in all the industrialized nations
• Covers statistical classification techniques and risk stratification
• Ayman S. El-Baz, Professor, University Scholar, and Chair of the Bioengineering Department, University of Louisville, USA.
• Jasjit S. Suri, Chairman of Global Biomedical Technologies, Inc.; Board Member, AtheroPoint, Roseville, CA, USA